Dr. Bazhenova on Considering Factors to Treat Non-Driver Patients With NSCLC With Bevacizumab

Evolving Paradigms, Non-Small Cell Lung Cancer, Volume 1, Issue 1

Lyudmila A. Bazhenova, MD, medical oncologist, professor of medicine, UC San Diego Health, discusses the factors to take into consideration when treating a patient with non-driver non–small cell lung cancer with bevacizumab (Avastin).